Research advances in the diagnosis and treatment of MASLD/MASH

Background: The global increase in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and its progression to Metabolic Dysfunction-Associated Steatohepatitis (MASH) pose significant public health challenges. This article offers a quick understanding of MASLD by providing: Metabolically Associated Fatty Liver Disease (MASLD), a globally prevalent liver disorder. Renamed from NAFLD in 2023, reflecting global consensus. Comprehensive review and evaluation of diagnostic methods over the past two decades. Summary and critical assessment of therapeutic approaches used in MASLD management. Strategic recommendations for future directions in MASLD diagnosis and treatment.